Ana Maria Aldea Perona, MD
Municipal Institute Of Medical Investigation
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dolores Ochoa Mazarro, MD
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Shared therapeutic areas:
Worked with same sponsors:
Rosa Maria Príncipe, MD
Hospital Pedro Hispano
Shared therapeutic areas:
Worked with same sponsors:
Serafim Guimarães, MD
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Shared therapeutic areas:
Worked with same sponsors:
Serafim Guimarães
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Shared therapeutic areas:
Worked with same sponsors:
Alberto Borobia Pérez, MD
Hospital Universitario La Paz
Shared therapeutic areas:
Worked with same sponsors:
Rosa Maria Antonijoan Arbós, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Worked with same sponsors:
Joana Cochicho, MD
Centro Hospitalar de Vila Nova de Gaia/Espinho
Shared therapeutic areas:
Worked with same sponsors:
Antonio Portolés Pérez, MD
Hospital Clinico San Carlos
Shared therapeutic areas:
Worked with same sponsors:
Daniela Machado Lopes, MD
Centro Hospitalar de Vila Nova de Gaia/Espinho
Shared therapeutic areas:
Worked with same sponsors:
Germán Soriano Pastor, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants
Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.
All 2 trials loaded